Cinta Folch1, Percy Fernández-Dávila2, Laia Ferrer3, Raúl Soriano4, Mercedes Díez5, Jordi Casabona6. 1. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Agència Salut Pública de Catalunya (ASPCAT), Generalitat de Catalunya, Badalona, Barcelona, España; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), España; Departament de Pediatria, d'Obstetrícia i Ginecologia, i de Medicina Preventiva i de Salut Pública, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, España. Electronic address: cfolch@iconcologia.net. 2. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Agència Salut Pública de Catalunya (ASPCAT), Generalitat de Catalunya, Badalona, Barcelona, España; Stop Sida, Barcelona, España. 3. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Agència Salut Pública de Catalunya (ASPCAT), Generalitat de Catalunya, Badalona, Barcelona, España; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), España. 4. Ministerio de Sanidad, Servicios Sociales e Igualdad, Madrid, España. 5. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), España; Ministerio de Sanidad, Servicios Sociales e Igualdad, Madrid, España. 6. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Agència Salut Pública de Catalunya (ASPCAT), Generalitat de Catalunya, Badalona, Barcelona, España; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), España; Departament de Pediatria, d'Obstetrícia i Ginecologia, i de Medicina Preventiva i de Salut Pública, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, España.
Abstract
BASIS AND OBJECTIVE: To describe the pattern of drug use among men who have sex with men (MSM) living in Spain and its association with sexual risk practices. MATERIAL AND METHOD: The European MSM Internet Survey was implemented in 2010 in 38 European countries on websites for MSM and collected data on sociodemographics, sexual behavior, and other sexual health variables. The association between unprotected anal intercourse (UAI) with casual partners and drug consumption was evaluated using multivariate logistic regression models. RESULTS: Among the 13,111 participants, most consumed drugs were cannabis (30.1%), popper (28.4%) and cocaine (18.7%). The risk of UAI with casual partners was 1.5 among those who had used drugs in relation to the other participants. The proportion of MSM who had injected drugs at least once in life was 2.5%, and 1.4% in the last 12 months. The prevalence of UAI with casual partners (53.4%), human immunodeficiency virus (HIV) (23%), hepatitis C (8.2%) and sexually transmitted infections (STI) (15.8%) was higher in MSM injectors related to those who had not used injected drugs (P<.05). CONCLUSIONS: The results of this study confirm a high prevalence of drug use in MSM and their relationship to sexual risk behavior. Although the use of injected drugs in MSM is a minority, this group reported a higher level of sexual risk behaviors, self-reported HIV, hepatitis C and other STI.
BASIS AND OBJECTIVE: To describe the pattern of drug use among men who have sex with men (MSM) living in Spain and its association with sexual risk practices. MATERIAL AND METHOD: The European MSM Internet Survey was implemented in 2010 in 38 European countries on websites for MSM and collected data on sociodemographics, sexual behavior, and other sexual health variables. The association between unprotected anal intercourse (UAI) with casual partners and drug consumption was evaluated using multivariate logistic regression models. RESULTS: Among the 13,111 participants, most consumed drugs were cannabis (30.1%), popper (28.4%) and cocaine (18.7%). The risk of UAI with casual partners was 1.5 among those who had used drugs in relation to the other participants. The proportion of MSM who had injected drugs at least once in life was 2.5%, and 1.4% in the last 12 months. The prevalence of UAI with casual partners (53.4%), human immunodeficiency virus (HIV) (23%), hepatitis C (8.2%) and sexually transmitted infections (STI) (15.8%) was higher in MSM injectors related to those who had not used injected drugs (P<.05). CONCLUSIONS: The results of this study confirm a high prevalence of drug use in MSM and their relationship to sexual risk behavior. Although the use of injected drugs in MSM is a minority, this group reported a higher level of sexual risk behaviors, self-reported HIV, hepatitis C and other STI.
Keywords:
Conductas de riesgo; Consumo de drogas; Hombres que tienen relaciones sexuales con hombres; Injection; Internet; Inyección; Men who have sex with men; Risk behaviors; Substance use
Authors: J Reyes-Urueña; C Campbell; C Hernando; N Vives; C Folch; L Ferrer; L Fernández-López; A Esteve; J Casabona Journal: Epidemiol Infect Date: 2017-03-08 Impact factor: 4.434
Authors: Noe Garin; Beatriz Zurita; Cesar Velasco; Anna Feliu; Mar Gutierrez; Montserrat Masip; M Antonia Mangues Journal: BMJ Open Date: 2017-01-18 Impact factor: 2.692
Authors: María José Fuster-RuizdeApodaca; Vanessa Castro-Granell; Ana Laguía; Ángeles Jaén; Santiago Cenoz; María José Galindo Journal: AIDS Res Ther Date: 2020-05-24 Impact factor: 2.250
Authors: Maria Jose Fuster-RuizdeApodaca; Vanessa Castro-Granell; Noé Garin; Ana Laguía; Ángeles Jaén; Carlos Iniesta; Santiago Cenoz; María José Galindo Journal: PLoS One Date: 2019-06-17 Impact factor: 3.240